WebFeb 13, 2024 · Penicillin is the most common drug allergy identified in medical records, with a prevalence ranging from 6 to 25% across various regions and treatment populations. 5,6 Benign cutaneous reactions ... WebDec 6, 2024 · The correction relates to the major determinant (benzylpenicilloyl octa-L-lysine) and the minor determinant (sodium benzylpenilloate). They are present following reconstruction in 1 ml solvent at concentrations of 8.6 × 10 −5 mol/L (related to eight benzylpenicilloyl moieties) and 1.5 × 10 −3 mol/L (for sodium benzylpenilloate) and not, …
Urticaria: recommendations from the Italian Society of Allergology ...
WebApr 1, 2024 · International Journal of Environmental Research and Public Health Contact allergy (sensitisation) and allergic contact dermatitis (ACD) resulting from it have a considerable public health impact. WebAllergology International is the official journal of the Japanese Society of Allergology and publishes original papers dealing with the etiology, diagnosis and treatment of allergic … in an ap the last term is 28
Collegium Internationale Allergologicum
WebJul 16, 2024 · Introduction: We aimed to investigate community-acquired pneumonia (CAP) requiring hospitalisation, empirically treated with β-lactam monotherapy, with 30-day mortality and risk factors predicting its complicated course. Material and methods: A prospective observational study was conducted at the Pulmonology and Allergology … WebNov 20, 2015 · Conclusions. An important role scientific societies should play is to advise on correct diagnostic and therapeutical pathways. For this reason SIAAIC decided to adhere to the Slow Medicine Italy campaign “Doing more does not mean doing better” with the aim of warning the scientific community and the citizens/patients about some allergological … Web1 day ago · Results. Dupilumab significantly improved the amount of systemic corticosteroid used and the frequency of exacerbation and compared with before dupilumab was used (p = 0.01 and <0.01, respectively).All patients could be weaned from systemic-corticosteroid therapy by 54 weeks of dupilumab use. in an app or on an app